Growth Metrics

Solid Biosciences (SLDB) Cash from Operations (2017 - 2026)

Quarterly results put Cash from Operations at 47230000.0 for Q1 2026, down 48.29% from a year ago — trailing twelve months through Mar 2026 was 171669000.0 (down 60.93% YoY), and the annual figure for FY2025 was 156289000.0, down 56.27%.

Solid Biosciences has reported Cash from Operations over the past 10 years, most recently at 47230000.0 for Q1 2026.

  • Cash from Operations reached 47230000.0 in Q1 2026 per SLDB's latest filing, up from 53555000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 15878000.0 in Q2 2022 and bottomed at 53555000.0 in Q4 2025.
  • Median Cash from Operations over the past 5 years was 27465000.0 (2023), compared with a mean of 29158117.65.
  • The largest annual shift saw Cash from Operations surged 39.61% in 2023 before it plummeted 80.65% in 2025.
  • Over 5 years, Cash from Operations stood at 34480000.0 in 2022, then soared by 39.61% to 20823000.0 in 2023, then crashed by 42.37% to 29645000.0 in 2024, then plummeted by 80.65% to 53555000.0 in 2025, then increased by 11.81% to 47230000.0 in 2026.
  • Business Quant data shows Cash from Operations for SLDB at 47230000.0 in Q1 2026, 53555000.0 in Q4 2025, and 33472000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -1.67 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.43 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 1.08 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 70.50 Mn
10 Solid Biosciences 713.77 Mn 333.09 Mn - -47.23 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -47.23 Mn
Mar 31, 2026 -47.23 Mn
Dec 31, 2025 -53.56 Mn
Dec 31, 2025 -53.56 Mn
Sep 30, 2025 -33.47 Mn
Sep 30, 2025 -33.47 Mn
Jun 30, 2025 -37.41 Mn
Jun 30, 2025 -37.41 Mn
Mar 31, 2025 -31.85 Mn
Mar 31, 2025 -31.85 Mn
Dec 31, 2024 -29.65 Mn
Dec 31, 2024 -29.65 Mn
Sep 30, 2024 -23.71 Mn
Sep 30, 2024 -23.71 Mn
Jun 30, 2024 -21.47 Mn
Jun 30, 2024 -21.47 Mn
Mar 31, 2024 -25.19 Mn
Mar 31, 2024 -25.19 Mn
Dec 31, 2023 -20.82 Mn
Dec 31, 2023 -20.82 Mn
Sep 30, 2023 -17.90 Mn
Sep 30, 2023 -17.90 Mn
Jun 30, 2023 -27.47 Mn
Jun 30, 2023 -27.47 Mn
Mar 31, 2023 -28.00 Mn
Mar 31, 2023 -28.00 Mn
Dec 31, 2022 -34.48 Mn
Dec 31, 2022 -34.48 Mn
Sep 30, 2022 -20.43 Mn
Sep 30, 2022 -20.43 Mn
Jun 30, 2022 -15.88 Mn
Jun 30, 2022 -15.88 Mn
Mar 31, 2022 -27.19 Mn
Mar 31, 2022 -27.19 Mn
Dec 31, 2021 -20.87 Mn
Dec 31, 2021 -20.87 Mn
Sep 30, 2021 -18.42 Mn
Sep 30, 2021 -18.42 Mn
Jun 30, 2021 -17.10 Mn
Jun 30, 2021 -17.10 Mn
Mar 31, 2021 -21.37 Mn
Mar 31, 2021 -21.37 Mn
Dec 31, 2020 1.31 Mn
Dec 31, 2020 1.31 Mn
Sep 30, 2020 -15.56 Mn
Sep 30, 2020 -15.56 Mn
Jun 30, 2020 -13.07 Mn
Jun 30, 2020 -13.07 Mn
Mar 31, 2020 -29.27 Mn
Mar 31, 2020 -29.27 Mn
Dec 31, 2019 -21.25 Mn
Dec 31, 2019 -21.25 Mn
Sep 30, 2019 -19.24 Mn
Sep 30, 2019 -19.24 Mn
Jun 30, 2019 -26.30 Mn
Jun 30, 2019 -26.30 Mn
Mar 31, 2019 -25.93 Mn
Mar 31, 2019 -25.93 Mn
Dec 31, 2018 -21.40 Mn
Dec 31, 2018 -21.40 Mn
Sep 30, 2018 -15.29 Mn
Sep 30, 2018 -15.29 Mn
Jun 30, 2018 -16.33 Mn
Jun 30, 2018 -16.33 Mn
Mar 31, 2018 -17.17 Mn
Mar 31, 2018 -17.17 Mn
Dec 31, 2017 -13.98 Mn
Dec 31, 2017 -13.98 Mn
Sep 30, 2017 -9.44 Mn
Sep 30, 2017 -9.44 Mn
Jun 30, 2017 -9.61 Mn
Jun 30, 2017 -9.61 Mn
Mar 31, 2017 -10.20 Mn
Mar 31, 2017 -10.20 Mn